Analystreport

DiaMedica Therapeutics Inc. (NASDAQ: DMAC) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.

DiaMedica Therapeutics Inc.  (DMAC) 
Last diamedica therapeutics inc. earnings: 11/13 04:12 pm Check Earnings Report